In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam

Chemical Research in Toxicology
R Scott ObachGregory S Walker

Abstract

Sudoxicam and meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class. While the only structural difference between the two NSAIDs is the presence of a methyl group on the C5-position of the 2-carboxamidothiazole motif in meloxicam, a marked difference in their toxicological profile in humans has been discerned. In clinical trials, sudoxicam was associated with several cases of severe hepatotoxicity that led to its discontinuation, while meloxicam has been in the market for over a decade and is devoid of hepatotoxicity. In an attempt to understand the biochemical basis for the differences in safety profile, an in vitro investigation of the metabolic pathways and covalent binding of the two NSAIDs was conducted in NADPH-supplemented human liver microsomes. Both compounds demonstrated NADPH-dependent covalent binding to human liver microsomes; however, the extent of binding of [(14)C]-meloxicam was approximately 2-fold greater than that of [(14)C]-sudoxicam. While inclusion of glutathione (GSH) in microsomal incubations resulted in a decrease in covalent binding for both NSAIDs, the reduction in binding was more pronounced for meloxicam. Metabolite identification studies on [(14)C]-sudoxicam in...Continue Reading

References

Mar 1, 1990·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T MizutaniK Nakanishi
Sep 15, 1980·Toxicology and Applied Pharmacology·R P HanzlikG J Traiger
Nov 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J SchmidH Wachsmuth
Mar 11, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C ChesnéT Sauter
Aug 7, 1999·The Journal of Biological Chemistry·L J MarnettC A Lanzo
Jun 27, 2001·Rheumatology·S H Roth
Mar 19, 2002·Chemical Research in Toxicology·Deepak K DalvieJohn P O'Donnell
Aug 20, 2003·The Journal of Biological Chemistry·Scott W RowlinsonLawrence J Marnett
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alaa RostomLoren Laine
Jun 25, 2005·Current Drug Metabolism·Amit S KalgutkarShawn P Harriman
Mar 27, 2007·Chemical Research in Toxicology·Tao JiRobert P Hanzlik

❮ Previous
Next ❯

Citations

Jan 8, 2011·Annual Review of Pharmacology and Toxicology·John S Walsh, Gerald T Miwa
Mar 8, 2012·Expert Opinion on Drug Metabolism & Toxicology·Freddi I ZunigaDiane D-S Tang-Liu
May 26, 2015·Expert Opinion on Drug Metabolism & Toxicology·Mark P Grillo
Sep 24, 2011·Drug Metabolism Reviews·Louis LeungR Scott Obach
Nov 21, 2014·Drug Metabolism Reviews·Deepak DalvieWeichao Chen
Jan 16, 2016·European Journal of Medicinal Chemistry·Debasis DasMoumita Bairagi
May 11, 2016·ACS Central Science·Amit S Kalgutkar
Feb 13, 2010·Neuropharmacology·Bruno BulicEckhard Mandelkow
May 11, 2016·ACS Central Science·Tyler B HughesS Joshua Swamidass
Oct 24, 2012·Medicinal Research Reviews·Andrew V StachulskiMartin S Lennard
Aug 20, 2015·ACS Medicinal Chemistry Letters·Honghe WanAshok V Purandare
Apr 11, 2015·Chemical Research in Toxicology·Jong Min ChoiSang Kyum Kim
Oct 9, 2014·Annual Review of Pharmacology and Toxicology·Amit S Kalgutkar, Deepak Dalvie
May 7, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David M StresserEric T Gangl
Apr 27, 2012·Journal of Medicinal Chemistry·David J St Jean, Christopher Fotsch
Jun 3, 2011·Chemical Reviews·Eliezer J BarreiroCarlos A M Fraga
Aug 16, 2014·Chemical Research in Toxicology·Abhishek SrivastavaVinayak P Hosagrahara
Mar 15, 2013·Journal of Medicinal Chemistry·Bruno BulicEckhard Mandelkow
Feb 22, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sraa Abu-Melha
Sep 15, 2018·Expert Opinion on Drug Metabolism & Toxicology·Chunyong He, Hong Wan
Jun 7, 2019·Drug Metabolism Reviews·S Cyrus KhojastehDonglu Zhang
Apr 24, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Amit S KalgutkarHeather Eng
Jul 10, 2020·Drug Metabolism Reviews·Chaitanya K JaladankiPrasad V Bharatam
Oct 1, 2020·Molecular Diversity·Seyed Aghil HooshmandAli Masoudi-Nejad
Oct 3, 2014·Molecular Pharmacology·Brooke M RockKent L Kunze
Apr 27, 2021·Chemical Research in Toxicology·Chaitanya K JaladankiPrasad V Bharatam
Dec 23, 2020·ACS Infectious Diseases·Andrew V StachulskiPaul M O'Neill
Jun 19, 2021·ACS Medicinal Chemistry Letters·Anthony J RoeckerChristopher S Burgey
Sep 10, 2019·Journal of Medicinal Chemistry·Amit S Kalgutkar
Aug 31, 2020·Chemico-biological Interactions·Žiga Jakopin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.